<DOC>
	<DOC>NCT02824809</DOC>
	<brief_summary>The Aims of the study are estimate the association between the severity of COPD and free testosterone level and the prevalence of hypogonadism in adult men with stable COPD</brief_summary>
	<brief_title>Association Between Testosterone Levels and COPD Severity</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Adults Men ≥ 45 years COPD defined according to clinical diagnosis and spirometry American thoracic society ( ATS) criteria Stable COPD without recent acute exacerbation (less than 2 weeks) Refusal to participate or informed consent process Those who are under treatment with testosterone replacement or antiandrogens Comorbidities: Cirrhosis, Alcoholism, cryptorchidism, panhypopituitarism, Pituitary adenoma. Orchiectomy Systemic glucocorticoids (equivalent dose ≥ 4 mg of prednisone in the last 3 weeks). Relative and absolute contraindications for spirometry.</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>hypogonadism</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Severity of Illness Index</keyword>
	<keyword>Testosterone</keyword>
</DOC>